DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

Clinical trial NCT06757244 · RECRUITING

Trial details

NCT number: NCT06757244
Sponsor: Hopital Foch
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Neoplasms

Start date: 2025-02-18
Primary completion: 2028-02-18
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.